Show simple item record

Authordc.contributor.authorRomán Román, Pablo 
Admission datedc.date.accessioned2019-01-29T15:47:36Z
Available datedc.date.available2019-01-29T15:47:36Z
Publication datedc.date.issued1991
Cita de ítemdc.identifier.citationRevista medica de Chile, Volumen 119, Issue 5, 2018, Pages 577-583
Identifierdc.identifier.issn00349887
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/162422
Abstractdc.description.abstractBetablockers may be classified according to their cardio selectivity, intrinsic sympathomimetic action and direct vasodilating action. All beta blockers reduce renin plasma levels, the effect being inversely proportional to the intrinsic sympathomimetic property. The hypotensive effect is related more to vasodilation than to a decrease in cardiac output. The hypotensive action is mediated by presynaptic beta receptors which normally stimulate noradrenaline secretion by nerve endings. Adverse effects, interaction with other drugs, and effects on risk factors of beta blockers are also reviewed.
Lenguagedc.language.isoen
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceRevista medica de Chile
Keywordsdc.subjectMedicine (all)
Títulodc.titlePharmacology of adrenergic beta receptor blockaders Farmacología de los beta-bloqueadores adreníergicos.
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorSCOPUS
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile